A study in humans with coronary artery disease identified the miR-541-3p as a biomarker for recurrent myocardial infarction risk, where it was downregulated in whole blood of patients with recurrent MI compared to those without, with this differential expression remaining significant after false discovery rate correction in a replication cohort [Onuoha et al. DOI:10.1111/cts.13307].